Previous 10 | Next 10 |
2024-03-14 21:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-07 14:11:15 ET Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Conference Call March 7, 2024 08:30 ET Company Participants Eric Sciorilli - Head of Investor Relations Terrie Curran - President & Chief Executive Officer Martin Gilligan - Chief Co...
2024-03-07 08:04:36 ET More on Phathom Pharmaceuticals Phathom Pharma Is A Buy Before July PDUFA Phathom Pharmaceuticals expands existing loan and security deal with Hercules Capital Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals Historical ea...
Launched VOQUEZNA® (vonoprazan) tablets in November 2023 for the treatment of Erosive GERD (gastroesophageal reflux disease), achieving net revenues of $0.7 million for the fourth quarter Early physician prescribing demonstrates strong demand for VOQUEZNA Secured expa...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Management to host conference call on Thursday, March 7, 2024, at 8:30 a.m. ET FLORHAM PARK, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestina...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
2024-02-16 16:37:46 ET Gainers: Iovance Biotherapeutics ( IOVA ) +4% . Microvision ( MVIS ) +3% . Iridium Communications ( IRDM ) +3% . Playtika Holding ( PLTK ) +2% . JetBlue Airways ( JBLU ) +2% . Losers...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $11.595 on volume of 119,263,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.8% to $4.3323 on volume of 111,414,526 shares SoundHound AI Inc. (SOUN) rose 0.0% to $3.7601 on volu...
One of the largest pharmacy benefit management (PBM) companies in the United States has added VOQUEZNA (vonoprazan) tablets to its national formularies for commercial plans, effective immediately FLORHAM PARK, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq...
News, Short Squeeze, Breakout and More Instantly...
Phathom Pharmaceuticals Inc. Company Name:
PHAT Stock Symbol:
NYSE Market:
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD) 1 New research on Erosive gastroesophageal reflux disease (GERD) demonstrating high health care resource utilization, real ...
Over 17,500 total prescriptions for VOQUEZNA® products have been dispensed, launch-to-date, a 361% increase since last quarterly report Ne...